Search PubMed⌕ Search

Biomedical subjects

C Cramer

Publications and source records attributed to C Cramer.

At least 37 records · Page 2Linked to original sources
PubMed1996

Who needs a nurse?

Explore the source record for details and available documents.

Clinical Competence↗
PubMed1996

Real nurses.

Explore the source record for details and available documents.

Clinical Competence↗
PubMed1996

[Adjuvant intraoperative radiotherapy of stomach carcinoma].

In order to evaluate the role of adjuvant IORT in the treatment of resectable gastric carcinoma, we carried out a randomized trial comparing surgery and surgery+adjuvant IORT. The study included 115 patients within a 74-month period, 51 of them received a single application of 28 Gy to the celiac axis. Patients were comparable with regard to age, sex, tumor stage and operative morbidity. The difference in mean survival time (IORT: 26.9 months vs. non-IORT, 30.8 months) and tumor-related death in the long-term course (mean follow-up period 29.2 months) with 29.4% (15/51) in the IORT-treated patients vs. 31.2% (20/64) in non-irradiated patients did not reach significance.

Combined Modality Therapy↗
PubMed1995

Jeremy.

Explore the source record for details and available documents.

Child↗
PubMed1995

A nurses bad day.

Explore the source record for details and available documents.

Adaptation, Psychological↗
PubMed1995

Belief.

Explore the source record for details and available documents.

Child↗
PubMed1991

[Long-term results of elective percutaneous transluminal coronary angioplasty. A clinico-angiography study of 289 consecutive patients].

289 consecutive patients (255 male, 34 female, 50 +/- 6 years) had an elective single-vessel-PTCA between October 1978 and March 1983. A clinical long-term follow-up was obtained after 4.7 (3-10) years. The PTCA success-rate was 73% with a non steerable balloon catheter being used in 95% of the cases. For 271/289 patients with follow-up (94%), the 56-month-survival rate was 96%, the incidence of non-fatal myocardial infarctions 11%, and the need for a second intervention (PTCA and/or bypass surgery) was 39%. The most favorable long-term outcome was observed in patients without need of a second intervention (97% survival, 7% non-fatal myocardial infarction, 83% without cardiac complaints during everyday life), and in patients with elective bypass surgery after an unsuccessful PTCA (100% survival, 5% myocardial infarction). 32/138 (23%) of patients without a second intervention during follow-up underwent an angiographic control after an average of 4.7 years. In comparison with the first follow-up angiogram 6 months after PTCA, the mean residual stenosis at the PTCA-site showed a slight decrease. It is concluded that PTCA offers good clinical and angio-graphic long-term results in single-vessel disease, with an excellent prognosis of patients without need for a second intervention.

Angioplasty, Balloon, Coronary↗
PubMed1987

Preoperative care unit. An alternative to the holding room.

Health care reimbursement practices are contributing to a decreased length of hospital stay. Subsequently, the time frame for surgical preparation has been reduced, and the hospital admission process has been considerably accelerated. The patient admitted the same day of surgery can experience a hurried sequence of events. Within hours the patient is interviewed by admitting department personnel, assessed by medical-surgical unit nursing staff, evaluated by "holding room" nurses, assessed by anesthesia staff, and introduced to the operating room personnel. This rushed environment may lend to a negative surgical experience and increased surgery-related stress. In contrast, establishing a preoperative care unit can increase surgical preparation time alotted to the patient by minimizing the number of personnel involved in the admitting process and decreasing physical transfer of the patient.

Facility Design and Construction↗
PubMed1987

Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.

In vitro studies were performed with 74 Pseudomonas aeruginosa isolates which were collected during a multicenter trial. The isolates were obtained from 70 patients who had been treated with netilmicin as the only antipseudomonal antibiotic. Clinically, 83% of the patients were cured or improved, and 64% of the Pseudomonas isolates were eliminated by chemotherapy. The 74 clinical isolates and 38 additional isolates with known mechanisms of aminoglycoside resistance were tested in three separate laboratories by disk diffusion methods and by microdilution tests with three broth media (Mueller-Hinton broth with full, half, and no cation supplements). Isolates that responded to netilmicin therapy and those that failed to respond were all susceptible by the disk test, and most were susceptible by microdilution tests with unsupplemented broth. However, over half of the clinical isolates appeared to be resistant when cations were added to the broth medium. Strains capable of producing enzymes that inactivate netilmicin were resistant by all methods tested. Broth dilution and agar dilution results were most comparable when half of the recommended cation supplements was added to Mueller-Hinton broth. Further consideration should be given to reducing the concentration of cations that are added to Mueller-Hinton broth when netilmicin susceptibility tests are being performed. However, additional studies with other aminoglycosides are needed before appropriate testing conditions can be standardized.

Adult↗